Clinical outcomes after immune checkpoint inhibitor-associated acute kidney injury: a cohort study
Clinical outcomes after immune checkpoint inhibitor-associated acute kidney injury: a cohort study
About this item
Full title
Author / Creator
Publisher
England: British Medical Journal Publishing Group
Journal title
Language
English
Formats
Publication information
Publisher
England: British Medical Journal Publishing Group
Subjects
More information
Scope and Contents
Contents
ObjectivesImmune checkpoint inhibitors (ICPi) have significantly improved survival for patients with advanced cancers. However, the occurrence of ICPi-associated acute kidney injury (AKI) and its clinical impact remains unclear. This study evaluates the effects of ICPi-associated AKI (ICPi-AKI) on mortality, kidney and cardiovascular outcomes in pa...
Alternative Titles
Full title
Clinical outcomes after immune checkpoint inhibitor-associated acute kidney injury: a cohort study
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_d945d051bf734ba0b456eb545e85617a
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d945d051bf734ba0b456eb545e85617a
Other Identifiers
ISSN
2044-6055
E-ISSN
2044-6055
DOI
10.1136/bmjopen-2024-092752
